NIH Locks Doors for Secret Drug Discovery Grant Reviews
Published Date: 12/3/2025
Notice
Summary
The Center for Scientific Review is holding a closed virtual meeting on January 26-27, 2026, to review grant applications for small business drug discovery projects. These meetings are private to protect secret ideas and personal info. Scientists and small businesses applying for grants should note this important review that helps decide funding but won’t cost or change anything for the public.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
NIH reviews small-business drug grant applications
If you are a small business or scientist applying for NIH small-business drug discovery grants, your grant applications will be reviewed by a Center for Scientific Review Special Emphasis Panel on January 26-27, 2026 from 10:00 a.m. to 6:00 p.m. The review is virtual and the panel will evaluate and decide on grant applications that determine funding.
Review closed to protect trade secrets and privacy
The meeting will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information about individuals associated with the grant applications.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2025-21872, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 27-28, 2026, to review grant applications focused on Alzheimer's and related brain diseases. These meetings are private to protect secret research ideas and personal info. Scientists and small businesses applying for grants should note this important review session, which helps decide who gets funding.
Next: 2025-21874, Sunshine Act Meetings
The SEC’s Crypto Task Force is holding a public meeting on December 15, 2025, to talk about financial surveillance and privacy. This meeting was delayed from October due to funding issues, but now it’s back on and open to everyone, either in person or online. If you signed up before, you’re already registered, so get ready to join the conversation without spending a dime!